Your Bank Wasn't Built For Your Business. Vellis Is.
Peptide businesses - whether you supply, manufacture or distribute research compounds - face account freezes and payment restrictions that generic providers aren't equipped to handle. Vellis provides payment processing directly - built for high-value orders, recurring client relationships and cross-border growth.
No intermediaries. You work directly with Vellis.
A fast-growing sector that traditional financial providers still get wrong.
Yet most payment processors still classify peptide businesses as high-risk by default.
Your payment infrastructure needs to scale with it.
A sector this advanced deserves better than generic payment restrictions.
The Real Problem
Peptide suppliers, manufacturers and distributors operate in a space that traditional payment processors have never been designed to serve. The compounds are legal. The businesses are legitimate. The infrastructure just wasn't built for them. Here's what that costs you.
Your payment processor flags or closes your account - without warning, without recourse.
Peptide research compounds are explicitly prohibited by most mainstream processors. Products such as BPC-157, TB-500, CJC-1295 or Ipamorelin are recognised by risk systems - and blocked. The result: your account is flagged or closed not because of anything your business has done wrong, but because your product category sits on a blanket exclusion list. Payments stop. Revenue freezes. And you're left waiting for a generic compliance team with no interest in reviewing the specifics of your operation. No dialogue. No timeline. No guarantee of resolution.
Getting paid for high-value B2B orders is harder than it should be.
Peptide businesses regularly process large, high-value orders from professional clients - research institutions, specialist distributors, healthcare providers. Generic payment infrastructure wasn't built for high-value, low-frequency B2B transactions in specialist product categories. Processing limits, risk flags on large orders and settlement delays all create friction in commercial relationships that depend on reliability and speed.
Every new market means rebuilding your payment setup from zero.
You've built a business that works. Now you want to expand - new distribution markets, international wholesale clients, cross-border supply agreements. And then it starts again: new processor, new application, new compliance review, new risk assessment. A business that shipped thousands of orders last year is treated like an unknown entity because the provider doesn't recognise your product category. Meanwhile, the opportunity sits ready and every week of delays is a week of revenue lost.
Your business banking is just as fragile as your payment processing.
Even when your processing holds up, your business bank account remains at risk. Traditional banks apply the same blanket exclusions to peptide businesses that payment processors do - and often without notice. Accounts get closed, transfers get delayed, and cash flow stops overnight. You lose the ability to pay suppliers, receive client payments and manage international operations. Rebuilding banking after de-banking takes months. Meanwhile, your business runs on borrowed time.
What Vellis Provides
Direct payment processing - built and operated by Vellis for the transaction profile, risk environment and growth ambitions of peptide suppliers, manufacturers and distributors.
Payment processing
Stable, category-aware processing
Accept payments for research compound orders online and via B2B channels, without sudden restrictions driven by product category.
Deposit & pre-payment collection
Protect your revenue from order cancellations with upfront payment collection built directly into your Vellis setup.
Recurring order billing
Manage wholesale accounts and repeat supply arrangements without manual follow-up.
Multi-currency checkout
Serve international clients in their currency with live market rates and no hidden margins added on top.
Chargeback & fraud monitoring
Calibrated to your transaction profile, not a generic retail risk model.
Business banking
Business accounts built for peptide operations
Hold and move funds without the account reviews and blanket exclusions that traditional banks apply to this sector.
Multi-currency accounts
Hold balances in multiple currencies to reduce unnecessary conversions when receiving international client payments and paying international suppliers.
Cross-border transfers
Send and receive supplier and client payments across jurisdictions with transparent pricing and no hidden intermediary deductions.
Foreign exchange at live market rates
Convert between currencies without the hidden margins traditional banks add to peptide business accounts.
Multi-entity structuring
Manage banking across group entities and jurisdictions through a unified setup, with a named point of contact throughout.
Pain Point to Outcome
What changes when your payment infrastructure actually fits your business.
Your current pain point
Account closed because processors won't handle your product category
High-value B2B orders flagged or delayed by generic risk systems
Repeat supply agreements managed on manual invoicing
International distributor and client friction across multiple markets
New distribution markets requiring a full payment setup rebuild
Cross-border supply chains disrupted by payment infrastructure failures
What you get with Vellis
Infrastructure built for peptide and specialty compound businesses - fewer flags and a direct point of contact when issues arise, rather than a generic compliance queue.
Processing better calibrated to professional client order profiles - large orders are less likely to trigger automatic holds, though your setup will still be monitored and reviewed over time as with any account.
Repeat order billing that works reliably - less admin, more operational efficiency.
Multi-currency checkout with live rates and no hidden margins.
Vellis onboards your business once - expanding into new markets doesn't mean starting from scratch every time.
Stable, international payment infrastructure built for specialist B2B distribution.
Why Vellis
Built for complex, regulated and emerging industries - with the track record to prove it.
Companies operating directly on Vellis infrastructure.
Industries served, from regulated healthcare to research supply.
Global
Coverage across multiple jurisdictions and currencies.
You work with Vellis as your authorized provider - one relationship, end to end. From your first consultation to your live account, every step is handled with a named point of contact. You always know who owns your setup, who to call, and what happens next.
We'd been turned away by three processors before finding Vellis. They understood our business immediately - no lengthy explanations, no back and forth about our product category. We were live within two weeks."
Founder, Specialty Peptide Supplier
Who We Work With
Vellis directly serves peptide businesses at every stage of growth - from independent suppliers to international manufacturers.
Peptide suppliers
Businesses supplying research compounds to laboratories, practitioners and wholesale clients locally and internationally.
Manufacturers & compounding facilities
Production operations managing high-value inventory, bulk orders and complex supply chains.
Distributors
Businesses managing multi-client, multi-market distribution of research compounds across jurisdictions.
Multi-location operations
Businesses that need payment infrastructure that scales across sites and markets as fast as they do.
How It Works
From first conversation to live infrastructure - handled directly by Vellis, start to finish.
Tell us about your business
Share your structure, product categories, order volumes and growth plans. Not a generic form - a real conversation with a Vellis specialist who understands the operational and regulatory environment peptide businesses work in.
We build the right setup for you
Vellis designs a payment configuration tailored to your order profile, jurisdiction and growth stage. An independent supplier and a multi-market manufacturer have different needs - your setup reflects that, not a generic catalogue.
Go live on Vellis infrastructure
Onboarding is guided by Vellis end-to-end. Once live, you operate directly on our infrastructure - with a dedicated point of contact, full visibility over your setup, and no middlemen in the chain.
Stop letting payment infrastructure limit what your business can supply.
The peptide research market is growing at 8% a year. Your payment infrastructure should grow with it - not flag it as a risk. 500+ businesses already operate directly on Vellis.
FAQ
Peptide Industry
Vellis is a direct provider - not a broker, not a referral service. We provide payment processing directly to your business. No intermediaries, no black boxes. You always know who owns your setup, who to contact, and how your payments are structured.
Yes - and it's the most common situation we encounter in this space. Most terminations happen because mainstream processors explicitly prohibit peptide product categories. A previous termination doesn't disqualify you. The only exception is if your business has been placed on a MATCH list.
Yes. Vellis operates globally, across any country that is not OFAC listed. We support peptide suppliers, manufacturers and distributors in Europe, the Middle East, Asia and beyond - including businesses with international wholesale clients and cross-border supply agreements.
Yes. We work with peptide businesses at every stage - from independent suppliers processing their first international orders, to established manufacturers managing high-volume, multi-market supply chains. The solution we build is always tailored to your actual structure and order profile.
Mainstream processors explicitly prohibit peptide product categories. Products like BPC-157, TB-500 or CJC-1295 are recognised by their risk systems - and blocked outright. Vellis processes payments through infrastructure built for complex and specialist product categories. Your transaction profile is understood from the start - not discovered mid-review. The only case where it would be difficult for us to help is if your business has been placed on a MATCH list.
Yes. Vellis supports upfront payment and deposit collection as part of your payment setup - so you can secure payment before fulfilling large or custom research orders without relying on manual processes or workarounds. If a client cancels or doesn't follow through, the payment has already been collected. We handle the setup so it works reliably from day one.
Yes, depending on your order management or e-commerce platform. If your existing system supports automated payment triggers via API, Vellis processes those payments reliably on the other end. The automation lives in your platform - Vellis handles the execution. If you're unsure whether your current setup supports this, we'll walk you through it during the consultation.
Yes. Vellis supports payments in a wide range of currencies, so international clients pay in their own currency without friction. Exchange rates reflect live market conditions - we don't add hidden margins or opaque fees on top. What you see is what you get.
It can, with generic providers. New or emerging research compounds are exactly what automated risk systems struggle with most - they default to flagging anything outside their standard classification. Vellis reviews your full product catalogue at onboarding and builds your setup around it, so expanding your range is less likely to trigger a compliance review down the line - though any significant catalogue changes are worth flagging to us proactively.
When a chargeback occurs, you have a direct point of contact at Vellis - not a generic support queue. We review the case with you, help gather the relevant documentation, and manage the process on your behalf.
A real conversation - not a sales pitch. Format and timing are flexible: call, video or email, based on your preference. A Vellis specialist will ask about your business structure, product categories, current payment setup, order volumes and growth plans. From there, you get a clear picture of what we'd recommend and what the process looks like. No pressure, no jargon, no commitment required.
For most businesses, the process is done within a couple of weeks. After your consultation, we give you a clear timeline based on your specific structure and jurisdiction - with no surprises mid-application.
Standard business documentation, plus any relevant licences, permits or regulatory authorisations applicable to your business and jurisdiction. Vellis gives you a complete, tailored document list upfront so there are no unexpected requests mid-process.